OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy vs. Immunotherapy in combating nCOVID19: An update
Abhigyan Choudhury, Gargi Mukherjee, Suprabhat Mukherjee
Human Immunology (2021) Vol. 82, Iss. 9, pp. 649-658
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

SARS-CoV-2: Receptor and Co-receptor Tropism Probability
Narges Eslami, Parisa Shiri Aghbash, Ali Shamekh, et al.
Current Microbiology (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 51

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
Zhimei Liu, Minghui Yang, Kun Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 49

Toll-like Receptor 4 in COVID-19: Friend Or foe?
Suprabhat Mukherjee
Future Virology (2022) Vol. 17, Iss. 7, pp. 415-417
Open Access | Times Cited: 45

SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19
Sabina Sahanic, Richard Hilbe, Christina Dünser, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21893-e21893
Open Access | Times Cited: 19

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
Jheng‐Yan Wu, Mei‐Yuan Liu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 18

Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Antibodies (2023) Vol. 12, Iss. 1, pp. 17-17
Open Access | Times Cited: 14

The Yin and Yang of TLR4 in COVID-19
Suprabhat Mukherjee, Jagadeesh Bayry
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 6

The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis
Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty, et al.
International Journal of Biological Macromolecules (2024), pp. 137836-137836
Closed Access | Times Cited: 5

Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity
Wael Alturaiki, Haitham Alkadi, Saad Alamri, et al.
Heliyon (2022) Vol. 9, Iss. 1, pp. e12653-e12653
Open Access | Times Cited: 20

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 4

Systematic review and meta‐analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS‐C) associated with SARS‐CoV‐2 infection
Golnaz Ghazizadeh Esslami, Setareh Mamishi, Babak Pourakbari, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 10

Myeloid‐Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID‐19
Cong Lai, Lu Su, Yilin Yang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Open Access

The picture theory of seven pathways associated with COVID-19 in the real world
Jong‐Hoon Lee, Consolato Sergi, Richard E. Kast, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2

Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection
Rounak Chourasia, Srichandan Padhi, Loreni Chiring Phukon, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9435-9454
Open Access | Times Cited: 9

Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China
Na Wu, Zhiwei Chen, Guanhua Zha, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 1

Aggravating mechanisms from COVID-19
Jong‐Hoon Lee, Consolato Sergi, Richard E. Kast, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Post COVID-19 complications, adjunct therapy explored, and steroidal after effects
Charu Sonkar, Vaishnavi Hase, Durba Banerjee, et al.
Canadian Journal of Chemistry (2022) Vol. 100, Iss. 7, pp. 459-474
Open Access | Times Cited: 4

The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae, and Vaccines
Marcelo Alarcón, Carolina Espinoza
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 16, pp. 2166-2185
Closed Access | Times Cited: 4

Comparative Computational Analysis of Spike Protein Structural Stability in SARS-CoV-2 Omicron Subvariants
Anand Balupuri, Jeong‐Min Kim, Kwang-Eun Choi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16069-16069
Open Access | Times Cited: 2

Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
Wenhui Yu, Yuxin Bai, Arjun Raha, et al.
Frontiers in Bioinformatics (2022) Vol. 1
Open Access | Times Cited: 3

The picture theory of seven pathways associated with COVID-19 in the real world
Jong‐Hoon Lee, Consolato Sergi, Richard E. Kast, et al.
Research Square (Research Square) (2024)
Open Access

In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins
Fatemeh Nafian, Ghazal Soleymani, Zahra Pourmanouchehri, et al.
Advances in Virology (2024) Vol. 2024, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top